ISS Immune System Stimulation AB

ABIn liquidation

Org 5567819841 · NACE Est. 20090 employees

Overview Financials People & ownership Related companies

ISS Immune System Stimulation AB is a Swedish AB. Incorporated in 2009, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2020

SEK 0

EBITDA margin

—

-12% vs 2018

Equity ratio

100.0%

Financial strength

Net profit 2020

SEK -19K

-12% vs 2018

EBITDA — year on year

SEK millions

Key figures

Annual report 2020

Revenue	SEK 0	—
EBITDA	SEK -19K	-12%
Net profit	SEK -19K	-12%
Total assets	SEK 10K	-58%
Equity	SEK 10K	-57%
Employees	0	—

Contact

Address

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of ISS Immune System Stimulation AB?

ISS Immune System Stimulation AB is registered with Bolagsverket / SCB under Org 5567819841.

Who is the CEO of ISS Immune System Stimulation AB?

Knut Olof Mikael Rosén is Liquidator of ISS Immune System Stimulation AB, in role since 2020.

Who is the chairman of ISS Immune System Stimulation AB?

Inger Margareta Dahle chairs the board of ISS Immune System Stimulation AB, in role since 2020.

ISS Immune System Stimulation AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on ISS Immune System Stimulation AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on ISS Immune System Stimulation AB